GSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...

However, Dr Raza said "awful" electricity costs could stunt growth and said the government should invest in renewable energy ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

GSK and Immunocore hope the TCRs can prove to ... anticipated to gain approval in late 2017/ early 2018. The privately-held, Oxford-based company says ImmTAC molecules offer a huge competitive ...

GlaxoSmithKline wants to sell more than a ... the heart of the UK's 'golden triangle', extending between London, Oxford and Cambridge, which houses the lion's share of the country's life science ...

GSK, the tenth biggest pharmaceutical company in the world, is investing £50 million to establish the GSK–Oxford Cancer Immuno-Prevention Programme, aimed at advancing the development of a ...

February 19, 2025 expert reaction to the announcement of the expansion of the OpenSAFELY data platform . Scientists comment on the expansion of the OpenSAFELY data platform. Prof ...

GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price looking cheap to me?

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...

London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing ...